clinical hold on pacritnib, breakthrough designation in sarcoma, and more
Published 8 years ago • 139 plays • Length 5:14Download video MP4
Download video MP3
Similar videos
-
7:40
clinical hold in all study, fda draft guidelines, expanded approval in hodgkin lymphoma
-
5:46
priority reviews in bladder cancer and hcc, clinical hold lifted in myelofibrosis, and more
-
1:15
pacritinib – is it safe for treating mf?
-
5:35
aaron gerds: what does the future hold for pacritinib?
-
1:31
risk-adjusted safety analysis of pacritinib for patients with mf
-
2:04
design and results of persist-1 trial of pacritinib for myelofibrosis
-
2:40
a curative treatment for cardiac fibrosis - prix musy 2023
-
8:44
priority review in nsclc, label update in cll, delayed fda decision in lung cancer, and more
-
1:24
the promising role of pacritinib for the treatment of patients with mf and severe thrombocytopenia
-
1:53
annette faller, m.d., internal medicine - mayo clinic health system
-
2:12
taking care of my heart - dr. michael mcconnell
-
2:40
initial approach to pv treatment
-
3:29
current approaches and new approvals in mf and pv
-
5:42
redesigning clinical trials in the era of precision medicine
-
1:06
the myspine experience - pre operative insights
-
1:16
medhold edge bipolar arthroscopic rf system product video
-
21:42
proposed concept clinical endpoints of long-term benefit | yura kim
-
2:52
medhold dr viola cmc arthroplasty using the apl and trushot with y knot shallow